Monitor · Newsflow
Market news
Equities, fixed income, macro, central-bank and regulator flow — every item sentiment-scored, impact-ranked and ticker-tagged.
- Business Wire·Jun 24, 2026HIGHAstraZeneca and YMCA of the USA Announce Landmark Partnership Aimed to Address Gaps in Cancer Care
- Business Wire·Jun 24, 2026HIGHAstraZeneca and YMCA of the USA Announce Landmark Partnership Aimed to Address Gaps in Cancer Care
- Zacks Investment Research·Jun 18, 2026Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note
- Zacks Investment Research·Jun 16, 2026FDA Accepts AstraZeneca's Filing for Expanded Use of Ultomiris
- Zacks Investment Research·Jun 16, 2026HIGHAstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?
- Zacks Investment Research·Jun 15, 2026HIGHAstraZeneca's Truqap Wins FDA Nod for Prostate Cancer Indication
- Zacks Investment Research·Jun 11, 2026HIGHAstrazeneca (AZN) Outperforms Broader Market: What You Need to Know
- Invezz·Jun 09, 2026HIGHAstraZeneca's obesity drug shows promise as analysts see upside beyond consensus
- Reuters·Jun 08, 2026HIGHAstraZeneca obesity pill helps patients lose 10.5% of body weight in trial
- GuruFocus·Jun 05, 2026NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
- PRNewsWire·Jun 05, 2026NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
- PRNewsWire·Jun 05, 2026NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
- Zacks Investment Research·Jun 03, 2026HIGHCan AstraZeneca's Expanding Cancer Portfolio Sustain Momentum?
- Benzinga·May 01, 2026HIGHAstraZeneca Prostate Drug Wins FDA Panel Backing As Breast Cancer Candidate Falters